ATE90342T1 - 1-hydroxyvitamin d2-epimer und dessen derivate. - Google Patents

1-hydroxyvitamin d2-epimer und dessen derivate.

Info

Publication number
ATE90342T1
ATE90342T1 AT90104564T AT90104564T ATE90342T1 AT E90342 T1 ATE90342 T1 AT E90342T1 AT 90104564 T AT90104564 T AT 90104564T AT 90104564 T AT90104564 T AT 90104564T AT E90342 T1 ATE90342 T1 AT E90342T1
Authority
AT
Austria
Prior art keywords
vitamin
hydroxy
derivatives
hydroxyvitamin
epimer
Prior art date
Application number
AT90104564T
Other languages
English (en)
Inventor
Hector F Deluca
Heinrich K Schnoes
Kato L Perlman
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE90342T1 publication Critical patent/ATE90342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90104564T 1989-03-09 1990-03-09 1-hydroxyvitamin d2-epimer und dessen derivate. ATE90342T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/321,254 US4973584A (en) 1989-03-09 1989-03-09 Novel 1α-hydroxyvitamin D2 epimer and derivatives

Publications (1)

Publication Number Publication Date
ATE90342T1 true ATE90342T1 (de) 1993-06-15

Family

ID=23249837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104564T ATE90342T1 (de) 1989-03-09 1990-03-09 1-hydroxyvitamin d2-epimer und dessen derivate.

Country Status (15)

Country Link
US (1) US4973584A (de)
EP (1) EP0386793B1 (de)
JP (1) JPH0737443B2 (de)
KR (1) KR950005776B1 (de)
AT (1) ATE90342T1 (de)
AU (1) AU631618B2 (de)
CA (1) CA1335105C (de)
DE (1) DE69001839T2 (de)
DK (1) DK0386793T3 (de)
ES (1) ES2055193T3 (de)
HU (1) HU207040B (de)
IL (1) IL93456A (de)
NZ (1) NZ232735A (de)
RU (1) RU2065851C1 (de)
WO (1) WO1990010619A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5756783A (en) * 1990-09-21 1998-05-26 Bone Care International, Inc. 1α-Hydroxy-24-EPI-vitamin D4
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US5786348A (en) * 1991-01-08 1998-07-28 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US5182396A (en) * 1991-03-29 1993-01-26 Nisshin Flour Milling Co., Ltd. 1-hydroxyvitamin d derivatives
DE69214617T2 (de) * 1991-12-26 1997-05-28 Wisconsin Alumni Res Found 26,27-Dimethylen-1-Alpha, 25-Dihydroxyvitamin-D2 und 26,27-Dihydroxyvitamin-D2 und Verfahren zu ihrer Herstellung
DE69318142T2 (de) * 1992-01-29 1998-09-17 Bone Care Int Inc 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
JP3179495B2 (ja) * 1992-08-28 2001-06-25 ボーン ケア インターナショナル インコーポレイテッド １α，２４（Ｓ）−ジヒドロキシビタミンＤ▲下２▼の調製及び使用方法
TW267161B (de) * 1992-11-20 1996-01-01 Hoffmann La Roche
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5373004A (en) * 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
US6416737B1 (en) 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
EP1745787B1 (de) * 1999-04-01 2016-11-09 Johns Hopkins University NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
JP2005500402A (ja) * 2001-08-22 2005-01-06 ジョンズ ホプキンス ユニバーシティ １α，２５−ジヒドロキシビタミンＤ３の２４−硫黄置換類縁体
WO2003106411A1 (en) 2002-06-13 2003-12-24 Johns Hopkins University 24-sulfoximine vitamin d3 compounds
WO2004054968A2 (en) 2002-12-18 2004-07-01 Johns Hopkins University 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol)
EP1656157B1 (de) * 2003-08-20 2011-12-21 Wisconsin Alumni Research Foundation 2-methylen-19-nor-vitamin d2-verbindungen
EP2393494A1 (de) 2009-01-27 2011-12-14 Berg Biosystems, LLC Vitamin d3 und seine analoga zur linderung der nebenwirkungen einer chemotherapie
CA2770683C (en) 2009-08-14 2018-09-04 Berg Biosystems, Llc Vitamin d3 and analogs thereof for treating alopecia
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US3907843A (en) * 1974-06-14 1975-09-23 Wisconsin Alumni Res Found 1{60 -Hydroxyergocalciferol and processes for preparing same
WO1984004527A1 (en) * 1983-05-09 1984-11-22 Wisconsin Alumni Res Found PROCESS FOR THE PREPARATION OF 1alpha,25-DIHYDROXYLATED VITAMIN D2 AND RELATED COMPOUNDS
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
US4717721A (en) * 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity

Also Published As

Publication number Publication date
AU5192590A (en) 1990-10-09
IL93456A (en) 1994-02-27
AU631618B2 (en) 1992-12-03
DK0386793T3 (da) 1993-08-02
KR950005776B1 (ko) 1995-05-30
KR920700201A (ko) 1992-02-19
HU207040B (en) 1993-03-01
HU902288D0 (en) 1991-07-29
US4973584A (en) 1990-11-27
DE69001839D1 (de) 1993-07-15
JPH0737443B2 (ja) 1995-04-26
NZ232735A (en) 1992-07-28
IL93456A0 (en) 1990-11-29
WO1990010619A1 (en) 1990-09-20
CA1335105C (en) 1995-04-04
RU2065851C1 (ru) 1996-08-27
ES2055193T3 (es) 1994-08-16
DE69001839T2 (de) 1993-09-16
JPH03504508A (ja) 1991-10-03
EP0386793B1 (de) 1993-06-09
EP0386793A1 (de) 1990-09-12

Similar Documents

Publication Publication Date Title
ATE90342T1 (de) 1-hydroxyvitamin d2-epimer und dessen derivate.
DE69006052D1 (de) 19-Nor-Vitamin-D-Derivate.
ATE69376T1 (de) Haarwuchsmittel.
ES515032A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
ZA878877B (en) Treatment of diseases caused by viruses
EP0494231A4 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ATE70069T1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
MX163341A (es) N procedimiento para la preparacion de nuevas 1,4 dihidropiridinas,utiles como medicamentos antibioticos
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT1184611B (it) Dispositivo per la produzione di aria sterile
ES2094757T3 (es) Un factor megacariocitopoyetico.
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
IT8621057A0 (it) La produzione di prodotti sessuali impiego di sostanze stimolanti per da mammiferi,adatti per la fecondazione naturale ed artificiale e sostanze relative
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
DE69331231T2 (de) Ein neuartiges, antineoplastisches cytokin
MC2152A1 (fr) Procede de preparation du 10,10-dioxyde de 1-ethylphenoxathiine et ce compose ainsi prepare
FR2637465B1 (fr) Procede de conservation, notamment d'algues fraiches
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee